In a gallbladder cancer mouse model, the inhibition of AIF1 leads to the decreased secretion of inflammatory factors and cell proliferation, augments cell apoptosis, and limits the invasion and epithelial-mesenchymal transition (EMT) of cancer cells via the TGF-β1/p38 pathway [142]. This evidence concerns the gene AIF1 and cancer.